CD47 and hepatocellular carcinoma: The blocking of CD47 was shown to enable macrophage-mediated phagocytosis of CSCs from pancreatic ductal adenocarcinoma (PDAC), AML, and hepatocellular carcinoma (HCC), and thus it promotes their elimination[45-47].